WO2010107761A1 - Improved storage and dispensing devices for administration of oral transmucosal dosage forms - Google Patents
Improved storage and dispensing devices for administration of oral transmucosal dosage forms Download PDFInfo
- Publication number
- WO2010107761A1 WO2010107761A1 PCT/US2010/027437 US2010027437W WO2010107761A1 WO 2010107761 A1 WO2010107761 A1 WO 2010107761A1 US 2010027437 W US2010027437 W US 2010027437W WO 2010107761 A1 WO2010107761 A1 WO 2010107761A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug
- patient
- rfid
- dispensing device
- dispensing
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title claims abstract description 102
- 238000003860 storage Methods 0.000 title description 6
- 230000001976 improved effect Effects 0.000 title description 3
- 239000003814 drug Substances 0.000 claims abstract description 183
- 229940079593 drug Drugs 0.000 claims abstract description 179
- 210000000707 wrist Anatomy 0.000 claims abstract description 23
- GGCSSNBKKAUURC-UHFFFAOYSA-N sufentanil Chemical compound C1CN(CCC=2SC=CC=2)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 GGCSSNBKKAUURC-UHFFFAOYSA-N 0.000 claims description 26
- 229960004739 sufentanil Drugs 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 21
- 239000012528 membrane Substances 0.000 claims description 10
- 239000004020 conductor Substances 0.000 claims description 6
- 210000002200 mouth mucosa Anatomy 0.000 abstract description 19
- 230000002457 bidirectional effect Effects 0.000 abstract description 6
- 239000003826 tablet Substances 0.000 description 41
- 210000003296 saliva Anatomy 0.000 description 20
- 238000012377 drug delivery Methods 0.000 description 12
- 238000002483 medication Methods 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 10
- 241001474791 Proboscis Species 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 238000003032 molecular docking Methods 0.000 description 9
- 210000003811 finger Anatomy 0.000 description 8
- 210000004379 membrane Anatomy 0.000 description 8
- -1 strip Substances 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 238000004806 packaging method and process Methods 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 210000003813 thumb Anatomy 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 230000006854 communication Effects 0.000 description 5
- 238000004891 communication Methods 0.000 description 5
- 238000001990 intravenous administration Methods 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000007909 solid dosage form Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000282414 Homo sapiens Species 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 239000002274 desiccant Substances 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000007937 lozenge Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 229940124597 therapeutic agent Drugs 0.000 description 4
- 229910000859 α-Fe Inorganic materials 0.000 description 4
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 208000000003 Breakthrough pain Diseases 0.000 description 3
- 206010028813 Nausea Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000004550 Postoperative Pain Diseases 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 239000013583 drug formulation Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000008693 nausea Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000005298 acute pain Diseases 0.000 description 2
- 239000000227 bioadhesive Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000007922 dissolution test Methods 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 238000010579 first pass effect Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- 239000012808 vapor phase Substances 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- 208000032484 Accidental exposure to product Diseases 0.000 description 1
- 206010049244 Ankyloglossia congenital Diseases 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 208000025940 Back injury Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010013710 Drug interaction Diseases 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000035032 Multiple sulfatase deficiency Diseases 0.000 description 1
- IDBPHNDTYPBSNI-UHFFFAOYSA-N N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide Chemical compound C1CN(CCN2C(N(CC)N=N2)=O)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 IDBPHNDTYPBSNI-UHFFFAOYSA-N 0.000 description 1
- 241001602876 Nata Species 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 208000000399 Procedural Pain Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- ZTVQQQVZCWLTDF-UHFFFAOYSA-N Remifentanil Chemical compound C1CN(CCC(=O)OC)CCC1(C(=O)OC)N(C(=O)CC)C1=CC=CC=C1 ZTVQQQVZCWLTDF-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- OJCZPLDERGDQRJ-UHFFFAOYSA-N Sufentanil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C1CN(CCC=2SC=CC=2)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 OJCZPLDERGDQRJ-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 231100000818 accidental exposure Toxicity 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 229960001391 alfentanil Drugs 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 230000007175 bidirectional communication Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 229950004689 carfentanil Drugs 0.000 description 1
- YDSDEBIZUNNPOB-UHFFFAOYSA-N carfentanil Chemical compound C1CN(CCC=2C=CC=CC=2)CCC1(C(=O)OC)N(C(=O)CC)C1=CC=CC=C1 YDSDEBIZUNNPOB-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229950010274 lofentanil Drugs 0.000 description 1
- IMYHGORQCPYVBZ-NLFFAJNJSA-N lofentanil Chemical compound CCC(=O)N([C@@]1([C@@H](CN(CCC=2C=CC=CC=2)CC1)C)C(=O)OC)C1=CC=CC=C1 IMYHGORQCPYVBZ-NLFFAJNJSA-N 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- BJZZDOLVVLWFHN-UHFFFAOYSA-N mirfentanil Chemical compound C=1C=COC=1C(=O)N(C=1N=CC=NC=1)C(CC1)CCN1CCC1=CC=CC=C1 BJZZDOLVVLWFHN-UHFFFAOYSA-N 0.000 description 1
- 229950002136 mirfentanil Drugs 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000006033 mucosulfatidosis Diseases 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960003394 remifentanil Drugs 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229960001204 sufentanil citrate Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- RJSCINHYBGMIFT-UHFFFAOYSA-N trefentanil Chemical compound C1CN(CCN2C(N(CC)N=N2)=O)CCC1(C=1C=CC=CC=1)N(C(=O)CC)C1=CC=CC=C1F RJSCINHYBGMIFT-UHFFFAOYSA-N 0.000 description 1
- 229950003235 trefentanil Drugs 0.000 description 1
- 229960003386 triazolam Drugs 0.000 description 1
- JOFWLTCLBGQGBO-UHFFFAOYSA-N triazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl JOFWLTCLBGQGBO-UHFFFAOYSA-N 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
- G16H10/65—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records stored on portable record carriers, e.g. on smartcards, RFID tags or CD
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0053—Syringes, pipettes or oral dispensers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0418—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with electronic history memory
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0427—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system
- A61J7/0436—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system resulting from removing a drug from, or opening, a container
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0427—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system
- A61J7/0445—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system for preventing drug dispensing during a predetermined time period
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0463—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers for multiple patients
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
- G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
- G06K19/067—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components
- G06K19/07—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components with integrated circuit chips
- G06K19/077—Constructional details, e.g. mounting of circuits in the carrier
- G06K19/07749—Constructional details, e.g. mounting of circuits in the carrier the record carrier being capable of non-contact communication, e.g. constructional details of the antenna of a non-contact smart card
- G06K19/07758—Constructional details, e.g. mounting of circuits in the carrier the record carrier being capable of non-contact communication, e.g. constructional details of the antenna of a non-contact smart card arrangements for adhering the record carrier to further objects or living beings, functioning as an identification tag
- G06K19/07762—Constructional details, e.g. mounting of circuits in the carrier the record carrier being capable of non-contact communication, e.g. constructional details of the antenna of a non-contact smart card arrangements for adhering the record carrier to further objects or living beings, functioning as an identification tag the adhering arrangement making the record carrier wearable, e.g. having the form of a ring, watch, glove or bracelet
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
- G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
- G06K19/067—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components
- G06K19/07—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components with integrated circuit chips
- G06K19/077—Constructional details, e.g. mounting of circuits in the carrier
- G06K19/07749—Constructional details, e.g. mounting of circuits in the carrier the record carrier being capable of non-contact communication, e.g. constructional details of the antenna of a non-contact smart card
- G06K19/07773—Antenna details
- G06K19/07777—Antenna details the antenna being of the inductive type
- G06K19/07779—Antenna details the antenna being of the inductive type the inductive antenna being a coil
- G06K19/07783—Antenna details the antenna being of the inductive type the inductive antenna being a coil the coil being planar
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- H04B5/77—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2200/00—General characteristics or adaptations
- A61J2200/30—Compliance analysis for taking medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/50—General identification or selection means using icons or symbolic figures, e.g. by a graphical representation symbolising the type of pathology or the organ by an image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/60—General identification or selection means using magnetic or electronic identifications, e.g. chips, RFID, electronic tags
Abstract
Dispensing devices and systems for oral transmucosal administration of small volume drug dosage forms to the oral mucosa are provided. The dispensing device may be a single dose applicator (SDA), or an electromechanical device comprising a means for patient identification such as a wrist worn RFID tag and annular bidirectional antenna together with a lock-out feature.
Description
IMPROVED STORAGE AND DISPENSING DEVICES FOR ADMINISTRATION OF ORAL TRANSMUCOSAL DOSAGE FORMS
Cross Reference to Other Applications
[0001] This application claims priority benefit of U.S. Provisional Application Serial No.
61/161,267, filed March 18, 2009.
Field of the Invention
[0002] The present invention relates to dispensing devices and systems for oral transmucosal administration of small volume drug dosage forms (tablets) to the oral mucosa. The dispensing device may be a single dose applicator (SDA) or an electromechanical device comprising a wrist worn RFID tag and annular bidirectional antenna.
Background of the Technology
[0003] Many medications that are dosed "as-needed" in a hospital or institutional setting require a restricted dosing schedule for safe self-administration.
[0004] Intravenous (IV) patient controlled analgesia (PCA) pumps are typically used to administer medications, such as opioids, for treatment of pain in the hospital or institutional setting, as well as on an outpatient basis. Using a preprogrammed PCA pump, the patient receives each dose of intravenous medication by activating a bedside button at allowable time intervals. If the button is activated during a time interval in which an allowable dose has already been administered, the pump is "locked out" and unable to deliver the dose until the appropriate time interval has passed. This prevents the patient from taking more than a maximum allowable dose of medication during a measured time interval.
[0005] There is a current focus on patient safety in medication administration, and the
Institute for Safe Medication Practices (ISMP) and the Joint Commission on the
Accreditation of Healthcare Organizations (JCAHO) have identified several consistently problematic areas in the use of IV PCA, the most problematic being human and pump errors, examples of which include pump programming errors based on entry of the wrong medication concentration; confusion over milligrams versus milliliters; the loading dose programmed as a bolus dose; the incorrect lockout time selected; and a PCA bolus dose confused with the basal rate. Also problematic is PCA by proxy, where the PCA button is activated by someone other than the patient, most commonly family members, nurses; or friends. See, e.g., Hicks, et al., Joint Commission on Quality and Patient Safety, 34(12),
734-742, 2008.
[0006] Oral mucosal drug delivery is an alternative method of systemic drug delivery that offers several advantages over both injectable, e.g., IV, and traditional oral routes of administration. The oral mucosa is highly vascularized, allowing lipophilic drugs to be readily absorbed through the oral mucosa and directly enter the systemic circulation, bypassing the gastrointestinal (GI) tract and first-pass metabolism in the liver.
[0007] Many medications have been evaluated for oral transmucosal delivery, however, few are commercially available. Further, although dispensing devices are available for the administration of a variety of types of medications, only inhaled medications are typically administered though the mouth using a device.
[0008] In addition, young children are vulnerable to inadvertent exposure to medications, in particular, when medications are not stored securely. Child-resistant packaging is required for many prescription medications as well as many household products. Child-resistant packaging together with "smart" packaging, has resulted in enhanced patient safety. "Smart" packaging or packaging-identification technology such as
Radio Frequency Identification (RFID) tags provide a viable means of medical-packaging traceability. RFID technology can provide controlled access to medications and help ensure patient safety and compliance.
Summary Of The Invention
[0009] Controlled access medication dispensers are provided by the claimed invention.
[0010] A radio frequency identification (RFID) system for patient identification is provided. The system comprises a handheld device having an RFID reader antenna, and a matching wrist worn RFID tag or inlay consisting essentially of a die or chip, a circuit and an antenna, wherein the antenna comprises annular conductors that circumvent the wrist.
The antenna field has an axis directed at the patient's hand, such that patient identification occurs when a handheld device comprising the reader antenna is held in the patient's hand, resulting in activation of the reader antenna.
[0011] The wrist worn RFID tag or inlay may be a bracelet and the RFID signal may be directional and symmetrical or bidirectional, but not symmetrical. In one embodiment, the distance between the handheld device and the wrist worn RFID tag or inlay is between 0 inches and 12 inches, between 0 and 8 inches, or between 0 and 6 inches.
[0012] Further provided is a drug dispensing system having a patient identification feature comprising the RFID system described hereinabove and methods of using the same.
[0013] In one embodiment, when the wrist worn RFID tag is removed, the RFID tag or inlay is damaged or destroyed and the drug dispensing system becomes non-functional.
[0014] In another embodiment, the dispensing device is activated and dispenses a drug dosage form following patient identification.
[0015] In yet another embodiment, the drug dispensing device system further comprises small volume drug dosage forms and a timed lock-out feature, wherein the timed lock-out feature provides for a set lock-out time, and the dispensing device cannot be activated during the set lock-out time.
[0016] The drug dispensing device system may further comprise a sufentanil- containing drug dosage form for use in the inpatient/hospital setting or in the outpatient setting.
[0017] In one further embodiment, methods for controlled access and safe administration of sufentanil to the oral mucosal membrane of a subject in the outpatient setting are provided.
[0018] In one aspect of this embodiment, a multiple single-dose dispenser (MSD) containing a plurality of single dose applicators (SDAs) is provided. Each SDA comprises a drug dosage form with an amount of sufentanil selected from the group consisting of
5mcg, lOmcg, 15mcg, 20mcg, 30mcg, 40mcg, 50mcg, 60mcg, 70mcg, 80mcg and lOOmcg, wherein the drug dosage forms have a volume of less than 30 microliters or a mass of less than 30mg.
[0019] The MSD may comprise one or more of the following features: (i) a lock-out feature adapted for setting a lock-out time such that an SDA cannot be removed from the
MSD during the lock-out time; (ii) a dose counting feature; (iii) a patient identification feature such as RFID; and (iv) a child resistant feature.
[0020] Each SDA may comprise: (i) two case halves that house the drug dosage form;
(ii) a label designed to provide for child resistance;(iii) a pusher; and (iv) a bridge feature that breaks away as the pusher is advanced to deliver a drug dosage form to the oral mucosal membrane.
Brief Description of the Drawings
[0021] Figure 1 is a photograph of a handheld and portable drug dispensing device and corresponding and RFID bracelet.
[0022] Figure 2 is a photograph of a handheld and portable device comprised of a disposable dispensing end, a reusable controller end and a disposable drug cartridge.
[0023] Figures 3A and 3B are schematic depictions of an exemplary RFID bracelet and an annular antenna.
[0024] Figure 4 is a schematic depiction of an exemplary dispensing device showing features designed to block or retard saliva and moisture ingress.
[0025] Figures 5A and B are schematic depictions of an exemplary geometry for a dispensing tip of a drug dispensing device.
[0026] Figures 6A - D are a schematic depiction of an exemplary proboscis of a drug dispensing device wherein the proboscis has an S-shape and comprises a shroud.
[0027] Figures 7A - B are schematic depictions of an exemplary single dose applicator
(SDA).
[0028] Figures 8A and 8B are photographs of exemplary multiple dose dispensers, holding a plurality of SDAs (Fig. 8A) and holding a plurality of SDAs and further showing an
SDA after removal the multiple dose dispenser (Fig. 8B).
[0029] Figures. 9A - C are schematic depictions of an exemplary multiple dose dispenser holding a plurality of SDAs.
[0030] Figures 1OA - C are schematic depictions of another exemplary multiple dose dispenser holding a plurality of SDAs. Included is a means for sensing when each SDA is removed from the device as well as a port which can be plugged into a computer do download user dose history information.
Detailed Description Of The Invention
[0031] The following disclosure describes handheld and portable drug dispensing devices, systems and methods for their use in oral transmucosal administration of small volume drug dosage forms. A detailed disclosure of the devices, systems and methods for administration of drug dosage forms are provided hereinbelow. The present invention generally encompasses: (1) drug dosage forms (tablets); (2) drug dispensing devices; (3) systems that include a drug dispensing device and a drug dosage form; and (4) methods for using such drug dispensing devices and systems.
[0032] The disclosure is generally directed to dispensing devices for dispensing any of a number of types of small volume dosage forms to the oral mucosa, methods of using such dispensing devices and systems comprising the same. The invention is not limited to the specific devices, systems and methodology or syndromes described herein, as these may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the
scope of the present invention.
[0033] It must be noted that as used herein and in the appended claims, the singular forms "a", "and", and "the" include plural references unless the context clearly dictates otherwise. Thus, for example, reference to "a drug formulation" includes a plurality of such formulations and reference to "a drug delivery device" includes systems comprising drug formulations and devices for containment, storage and delivery of such formulations. [0034] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood to one of ordinary skill in the art to which this invention belongs. Although any methods, devices and materials similar or equivalent to those described herein can be used in the practice or testing of the invention, the preferred methods, devices and materials are now described.
DEFINITIONS
[0035] The terms "formulation" and "drug formulation" or "drug dosage form" as used herein refer to a physical composition containing at least one therapeutic agent, which may be provided in any of a number of dosage forms for delivery to a subject. The dosage form may be provided to the patient as a lozenge, pill, capsule, membrane, strip, liquid, patch, pad, film, gum, gel, spray or other form. In one embodiment, the drug dosage form is a solid, e.g., a lozenge, a pill, a tablet, a membrane or a strip. The claimed "drug dosage forms" are also referred to herein as tablets.
[0036] The term "drug" as used herein is generally meant to refer to any substance that alters the physiology of an animal. The term "drug" may be used interchangeably herein with the terms "therapeutic agent", "medication", "pharmacologically active agent" and the like. It will be understood that a "drug" formulation may include more than one therapeutic agent, wherein exemplary combinations of therapeutic agents include a combination of two or more drugs.
[0037] The term "subject" includes any subject, generally a mammal (e.g., human, canine, feline, equine, bovine, ungulate etc.), adult or child, in which treatment for a disorder is desired. The terms "subject" and "patient" may be used interchangeably herein. [0038] The term "trans mucosa I" delivery of a drug and the like is meant to encompass all forms of delivery across or through a mucous membrane. In particular, "oral transmucosal drug delivery" and "oral transmucosal administration" as used herein refer to drug delivery that occurs substantially via the oral transmucosal route and not via swallowing followed by GI absorption. This includes delivery via buccal, sublingual and gum
transmucosal areas. Transmucosal dosage forms are designed to provide for a dissolution/erosion rate that allows for maximal delivery via the oral mucosa, typically via placement of the dosage form in the sublingual cavity.
[0039] As used herein, "sublingual", means literally "under the tongue" and refers to a method of administering substances via the mouth in such a way that the substances are rapidly absorbed via the blood vessels under the tongue rather than via the digestive tract. Absorption occurs via highly vascularized mucosa and allows a substance more direct access to the blood circulation, providing for direct systemic administration independent of gastro-intestinal influences.
[0040] The term "treatment" or "management" of a medical disorder or condition is used herein to generally describe regression, suppression, or mitigation of symptoms of the medical disorder or condition so as to make the subject more comfortable as determined by subjective criteria, objective criteria, or both.
[0041] "Operatively connected" as used herein means the components are provided in a device so as to function as intended to achieve an aim. For example, a memory device operatively connected to a CPU which is further operatively connected to a release mechanism may be meant to indicate that, upon actuation, the CPU communicates with the memory device to check the status or history of drug delivery, and then further communicates with the release mechanism (e.g., via a solenoid and a switch) to release and dispense a drug.
[0042] The term "FOB" refers to a small, portable handheld, powered electronic docking device that can be used in conjunction with the drug dispensing device to upload data, download data, control access to the drug dispensing device, control access to the drug dosage forms, or enhance or otherwise alter the user interface of the drug dispensing device. A FOB may communicate and dock with a drug dispensing device either in a wired or wireless fashion. A FOB may be adapted to attach to a cord so as to allow the FOB to hang from the neck of a patient, or healthcare professional such as a physician or caregiver, particularly in the hospital setting. A drug dispensing device may communicate with a physician or care giver via the FOB.
[0043] The terms "dispensing device", "drug dispensing device", "dispenser", "drug dispenser", "drug dosage dispenser" and "drug delivery device", are used interchangeably herein with the term "dispensing device" and refer to a device that dispenses a drug dosage form. A single dose applicator is considered to be a "drug dispensing device". The dispensing device provides a mechanism for controlled and safe delivery of a medication
formulated in a dosage form for delivery to the oral mucosa of a patient and is adapted for storage and/or delivery of a dosage form such as a lozenge, pill, tablet, capsule, membrane, strip, liquid, patch, film, strip, gel, spray or other form. [0044] The term "systems that include a drug dosage form and a dispensing device" as used herein refers to a drug dispensing system for delivery and/or monitoring of drug administration. A system may be used to monitor and deliver both efficacious and safe dosages such that the amount of drug delivered, and the corresponding safety and efficacy are enhanced over currently available systems. The system may have one or more features that provide for improved safety and ease of use over currently available systems including a security feature that prevents unauthorized access to the stored drugs, such as a dosing lock-out feature, a dose counting feature, a memory means for retaining information about dose delivery, and an interface for bidirectional exchange of information with a user, a drug cartridge, or another device such as a computer, as well as a means for identifying a device user such as the patient or a health care provider in order to provide for controlled drug access.
[0045] The term "proboscis" is used interchangeably with the terms "dispensing tip" and "delivery tip", and refers to a dispensing and/or positioning tip of a drug dispenser that delivers a dosage form to a desired location (e.g. the oral mucosa). [0046] The term "shroud" is used to describe a partial or complete covering of the delivery port of the proboscis to protect the delivery port from contact with saliva or other moisture in the oral cavity.
Features of Dispensing Devices
[0047] One exemplary embodiment of the drug dispensing device is handheld and portable, as shown in Fig. 1. This embodiment of the drug dispensing device has a disposable dispensing end 189 and a reusable controller 191. In this embodiment, a disposable drug cartridge 17 is locked into place when the disposable dispensing end 189, and reusable controller end 191 are latched to one another (Fig. 2). In another embodiment, the device is capable of dispensing multiple drug dosage forms, a single dose at a time for delivery via the oral mucosa, e.g., into the sublingual or buccal space. [0048] The drug dispensing device has a housing with a dispensing end which typically has a proboscis with a shroud which can block or retard saliva ingress and saliva contact with the tablet exit port, as further described herein below. [0049] In some embodiments of the invention, the drug dispensing device is manually
actuated and fully disposable, e.g., a single dose applicator (SDA). [0050] In other embodiments, the drug dispensing device is actuated by an electromechanical means. The claimed drug dispensing devices have a number of additional features, further described below.
User Identification Feature
[0051] The claimed dispensing devices comprise a detecting means for patient identification such as: fingerprint identification; RFID detection with the use of an active or passive RFID tag on a bracelet, necklace, clip, belt, strap, ring, adhesive patch (e.g., on the finger or thumb of the patient), or an implant, or other means of locating and affixing the tag; retinal identification; DNA identification; voice recognition; password or code entry; physical key; electronic or magnetic key; personal area network identification using the human body or clothing as a data or signal conduit; optical scanner or face recognition; sonic; subsonic or ultrasonic identification; or any other means of identifying an individual and verifying their identity. The dispensing device may employ one or more means to identify the user, enabling the system to determine if a dispensing request is being made in an authorized or unauthorized manner.
[0052] It is important for effective delivery of many drugs to ensure that the dispensing device is not accidentally or intentionally used by an unauthorized individual thus preventing accidental or intentional diversion of the drug. Such user identification systems may recognize one or more users, for example, in an inpatient hospital setting the dispensing device can be programmed to recognize the patient to whom it is prescribed, and/or an authorized healthcare provider such as a nurse or physician. [0053] One method of user identification is the use of a short distance ("near field") passive RFID tag attached to a bracelet, a necklace, an adhesive patch placed on the end of the patient's finger or thumb, a ring, a clothing tag, an orally mounted device such as an orthodontic retainer, a belt, a strap, some combination of the above, or another location. When an RFID tag is used in the "near field", roughly defined as about 16% of the wavelength of the received signal, the tag behaves in the inductive mode of operation, coupling the reader and tag antenna magnetically. The near field is characterized by at least two features: first, a rapid decline in field strength with distance, and second, a strong directionality of the signal. In the near field, the signal strength falls off very rapidly, with a signal strength loss of approximately 6OdB per decade in distance. Good inductive coupling between the transmitter antenna and the RFID tag antenna occurs when
two antennas are oriented in parallel planes with the axes through the center of each antenna in close proximity. A second orientation for good inductive coupling is when the two antennas are oriented in the same plane, and in close proximity. Strong signal strength (robust user identification) is provided when the device is very close to the RFID tag (as exemplified by the system shown in Fig. 1; details of a RFID bracelet embodiment shown in Fig. 3A and details of an RFID antenna embodiment shown in Fig. 3B). At the same time, a very poor signal is provided when the device is further away or misaligned from the tag, which helps prevent unauthorized use by someone other than the patient who attempts to use the device. It is preferable to operate in this near field region with good antenna alignment. Furthermore, it is preferable to operate with a very short distance of adequate signal strength for a positive identification, so that it is very difficult to receive a signal if the device is not in the proper orientation and proximity to the RFID tag. To attain a short distance and a proper alignment between antennas, the dispensing device may be designed so as to properly locate the RFID reader antenna, mounted in the dispensing device, adjacent an RFID tag antenna, mounted, for example, on a wrist band or bracelet, a finger or thumb ring, or a clothing tag on the collar, or an adhesive patch on the hand, arm, cheek, neck, or elsewhere. Furthermore, an RFID tag antenna on a wrist band or bracelet may be held in proper alignment and location by means of a small adhesive patch that prevents the bracelet from moving or rotating on the wrist. [0054] RFID technology is widely utilized for inventory, logistical tracking, and other supply chain and related functions. A passive RFID tag includes a chip and an antenna and when exposed to, and energized by, radio-frequency energy from the RFID reader, the tag transmits its identification which is captured by the reader. A tag may have either read functionality or read/write functionality. An active RFID tag operates in the same manner as a passive RFID tag, except it has its own power source, such as a battery. [0055] An RFID tag, inlay or label comprises an RFID die or chip component (comprising an electronic identification circuit and a coupling means), a circuit and an antenna structure coupled to the coupling means. This tag component can be embedded into a bracelet, necklace, ring, adhesive patch, clothing tag, orally mounted device, belt, strap, or combination there of - any of which may be worn by the patient. An exemplary wrist worn RFID tag, or bracelet, is shown in Fig. 1 and a detailed embodiment is shown in Fig. 3A. In Fig. 3A, the conductor is wrapped one or more times around the wrist such that the antenna axis is effectively parallel to the axis of the wrist and forearm. This configuration allows for a wrist worn RFID tag such as a bracelet to have a directional
orientation aligned toward a device in the palm of one's hand as shown in Fig. 3A. The fixed orientation allows coupling with the RFID reader housed within a handheld device. Figure 3A shows an RFID circuit board 179, a coiled conductor antenna 177, an annular antenna on the RFID bracelet 183, where the annular antenna produces an electromagnetic field directed towards one's hand 181. Providing this directionality is not possible with existing RFID bracelet technology.
[0056] The claimed RFID tag, inlay or label comprises a die or chip, a circuit and antenna that includes one or more wraps of a conductor 187 that circumvent the wrist to form a bracelet 173 as shown in Figs. 1 and 3A.
[0057] There is a continuing, unfilled need for devices, methods, and systems comprising a wrist worn RFID tag which can couple or communicate with a handheld device permitting patient identification by the handheld device. The present invention addresses this need.
[0058] In one example of this embodiment, the dispensing device employs a high frequency RFID reader for use in the inpatient (hospital, clinic, etc.) setting, operating on or near the 13.56MHz frequency band, and the patient is fitted with a disposable version of the aforementioned RFID bracelet with annular antenna designed in such a way that if the bracelet or wrist band is removed, the RFID tag, its antenna, or another component of the associated circuit is damaged or destroyed, rendering the bracelet or wrist band nonfunctional. In one example, the range of the RFID communication is short, between 0 inches and 12 inches preferably, more preferably between O and 8 inches, and most preferably between O and 6 inches.
[0059] In one preferred embodiment, the RFID signal is directional and symmetrical, allowing proper use by the intended patient to be transparent, usable by right or left hands equally, easy and reliable, while at the same time making unauthorized use by another individual difficult.
[0060] In another embodiment, the RFID reader antenna employs a ferrite 185 to direct or focus the field toward the RFID tag, as shown in Fig. 3B. The ferrite antenna is bidirectional but not symmetrical, having a coiled conductor 187, e.g., made of ferrite 185, such that the RFID tag is designed to work equally well when the RFID reader device is held in either the left or right hand (Figure 3B). Additionally, this ferrite antenna provides for increased range and increased directionality. Finαer or Thumb Patch RFID Taα [0061] In yet another embodiment, the RFID tag is provided as a patch or sticker,
which is designed to be attached (adhered) to the end of a finger or the thumb of a patient. The patch or sticker may be attached to any area around the finger or hand, including the pad side or the nail side of the fingers/thumb. The patch typically comprises a microchip attached to an antenna which is packaged in a way that it adheres to the end of a finger or the thumb of a patient for the period of time that a given dispensing device is used by the patient. The tag picks up signals from and sends signals to a reader contained within a drug dispensing device. The tag contains unique information, specific to the reader located in the dispensing device it is paired with. The reader has one or more antennas, which emit radio waves and receive signals back from the tag. When the finger or thumb patch is held sufficiently close to the drug dispensing device, the reader receives a signal which enables the dispensing device to dispense a dosage form, so long as the device is not in a timed lock-out period.
Lock Out
[0062] In one embodiment, the dispensing device has a timed lock-out feature which provides for a set lock out time at regular intervals or time periods.
[0063] The timed lock-out period for the claimed dispensing device is typically from 5 minutes to 60 minutes, from 10 minutes to 40 minutes, from 15 minutes to 30 minutes, typically 15 or 20 minutes. The timed lock-out period may be set at any one minute interval from 5 to 60 minutes, e.g., 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 ,16, 17, 18, 19, 20,
21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39,40, 41, 42, 43 ,44,
45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59 or 60 minutes. The lock-out time is typically preset, however, the dispensing device may provide a means for adjusting the lock-out time.
[0064] There can also be a second tier lockout, for example a scenario where the patient is permitted to take a tablet once every 20 minutes, not to exceed 12 doses in a 24 hour period.
Blocking /Retarding Saliva and Moisture Ingress
[0065] In some embodiments, the device comprises a means for minimizing or eliminating saliva ingress and moisture ingress onto and into the device: (1) to avoid wetting the dosage forms therein, whether in the dispensing track or in the primary dosage package (cartridge); (2) to isolate any saliva that enters the dispensing device in such a manner that the dosage forms therein remain dry; (3) to absorb or adsorb any saliva that
enters the dispensing device in such a manner that the dosage forms remain dry; (4) to block saliva and moisture from entering the device, to protect the dosage forms from vapor and liquid phase moisture; (5) to block incidental contact of the tongue or mucosa on the tablet exit port or proboscis that can lead to wetting and ultimately the adherence of the tablet to the device, or (6) any combination thereof.
[0066] The device may also comprise a means for preventing and/or controlling humidity ingress into and within the device due to ambient conditions outside the device. The dispensing device may rely on valves, pads, seals, the rest position of push rod, proboscis design and a shroud to minimize or eliminate saliva ingress or moisture into the dispensing device during administration of the dosage forms. [0067] The means for minimizing or eliminating saliva ingress or preventing other moisture from entering the dispensing device includes, but is not limited to, one or more flexible or rigid seals, valves, one or more flexible or rigid wipers, use of one or more absorbent material components such as a desiccant or pad, a door or latch that is manually or automatically opened and closed, multiple stage delivery systems, a positive air pressure and airflow, or an air gap or prescribed distance or barrier/shroud maintained between the tablet delivery orifice and the mucus membrane tissues within the mouth that may transport the saliva. The shroud limits the ability of the tongue or oral mucosa to contact the dosage form dispensing area, thereby controlling saliva contact and ingress. [0068] Means for trapping or otherwise isolating saliva or moisture once it has entered the device are described in detail in U.S. Patent Publication Nos. 20070186923, 20080164275, 20080268023 and PCT Publication Nos. WO 2007/081947, WO2008/085763 and WO2008/085764.
[0069] To protect the drug dosage forms from exposure to moisture either from humidity, saliva ingress, or accidental exposure to other water based liquids, the dispensing device and the container or cartridge which houses the dosage form within the device may or may not contain a desiccant.
[0070] The proboscis design for use in the device is characterized by a distal device shape, typically an S-shape, that aids in use of the device and/or placement of the tip on the oral mucosa of the subject. The shape typically has curves, angles, and geometries such that it enables proper use of the device and placement of the dosage form on the oral mucosa of the subject, e.g., in the sublingual space.
[0071] Figure 4 is a schematic depiction of an exemplary dispensing device wherein the dispensing tip comprises a shroud 29 having a one or more of: a wiping or sealing valve 33
or 35, an absorbent pad 39, a drug drying chamber/moisture communication channel 43, desiccant in the channel 45, a cartridge 17 containing dosage forms 67 and desiccant in the cartridge 47.
[0072] Figures 5A and B are schematic depictions of an exemplary geometry for a dispensing tip that prevents contact of one or more seals 33, 35 with the moist or wet surface of the oral mucosa via a shroud 29.
[0073] Figs. 6A - D are a schematic depiction of an exemplary proboscis 31 of the dispensing device wherein the proboscis 31 has an S-shape 53 and comprises a shroud 29, a valve 33 for dispensing a dosage form 67 and a cut-out/relief 55 for the dosage form to be placed against the oral mucosa and not moved when the device is withdrawn following dispensing. The shroud shields the valve from moisture and saliva ingress from the tongue and other mucosa and provides an area for the dosage form to exit the device without "sticking" to the wetted distal valve or shroud area. The valve functions with the shroud to control saliva and moisture ingress, as well as aid in delivery of the dosage form. [0074] The claimed drug dispensing may be used to administer a tablet that is sensitive to moisture and/or humidity. In some cases, the dispensing device includes a tablet cartridge 17 (e.g., as shown in Fig. 2) that protects the tablet from liquid and vapor phase moisture, including humidity, liquid moisture, saliva, mucus, etc. The cartridge may be cylindrical, disk-shaped, helical, rectilinear, non-ordered, or may take the form of any assemblage of tablets that allows the drug dispensing device to dispense them in a controlled manner. To prevent the unused tablets from absorbing moisture or otherwise becoming exposed to moisture prior to use, the cartridge may provide a means of sealing the tablets from exposure to moisture. In some embodiments, all of the tablets in a cartridge may be packaged together in a foil sealed compartment. [0075] In the case of medications, such as sufentanil, that are sensitive to oxygen when provided as a solid tablet, the primary package (e.g., a cartridge), may contain the solid sufentanil tablet and an oxygen scavenger, as a means to minimize or eliminate generation of oxidative degradation products upon storage, as detailed in U.S. Patent Application No. 12/275,485.
[0076] The pushrod design of the dispensing device is described in U.S. Patent Publication Nos. 20070186923 and 20080164275.
Dosing History/ Feedback
[0077] Further embodiments of the device include the ability to store historical use
information and the ability to transmit such information. The device may be capable of unidirectional (downloading) or bidirectional information transfer. For example, such an exchange of information may be accomplished by downloading stored information to a computer through a physically wired interface, such as a USB or other communication connection. Alternatively, information may be communicated via a wireless system, e.g. Bluetooth, Wifi, or other RF technology.
[0078] In another embodiment, the dispensing device has a dose counting feature that monitors and stores the history of drug usage. Such information may include historical use information, for example the number of dosages stored and dispensed, the state of the dispenser, and the times of dispensing. Device Setup
[0079] The claimed dispensing device may be capable of self-calibration of the dispense mechanism, or the device may be calibrated manually. This process may employ a "shipping tablet" as the first tablet dispensed from the device. This shipping tablet has a feature or features that differentiate it from a drug-containing tablet and the push rod. The differentiating feature may be physical, optical, RF, electronic or magnetic. This features can be recognized by the device during setup to ensure that the device is working correctly without requiring the dispensing of a drug-containing tablet. This approach also confirms, during setup, that a 'new cartridge' is being used.
Additional Features
[0080] The claimed dispensing device may also provide the ability to recognize a specific cartridge by a mechanical, optical (e.g. bar code), electronic (e.g. microchip), magnetic, radio frequency, chemical, or other means of detecting and identifying the cartridge. In one exemplary embodiment of the invention, the cartridge contains a physical keying detail on the cartridge that is physically detected by a sensor or switch or a series of sensors or switches in the dispensing device. Furthermore, the dispensing device may communicate uni-directionally or bi-directionally with the cartridge to exchange information. Such information may include drug name, dosage strength, usage information, lockout period, manufacturing lot number, indications for use, side effects, drug interactions, date of manufacture, date of expiration, serial number, number of doses in the cartridge, or any other relevant information. The dispensing device may be able to write, in addition to read, information to the cartridge, like date used, health care provider or patient identification, number of doses remaining, etc.
[0081] The claimed dispensing device provides mechanical protection for the dosage forms contained therein, preventing breakage, chipping, hydration etc., thereby allowing for dispensing of the undamaged dosage forms contained therein. This is of particular importance for small fragile and friable dosage forms.
[0082] The drug dispensing device may be powered by a battery, capacitor, fuel cell, external electrical power supply, or other power supply source, or may require no electrical power, but be manually activated.
[0083] In some embodiments, the dispensing device is capable of issuing alarms or other notifications when functional or safety issues arise. The alarm or other notification may trigger an alert on the dispensing device, on a dock or other peripheral device; on a computer or by means of a wired or wireless network, or may alert other remote devices. The alarm or notification may be audible, tactile, visual, or may employ other means of notifying one or more individuals.
Base Station/ Docking Station
[0084] In some embodiments the drug dispensing system includes a base station for recharging one or more drug dispensing devices and a portable docking FOB between uses. In addition to recharging the drug dispensing devices and FOBs, the base station may provide one or more of the following functionality: wireless or wired connectivity to a peripheral device, computer or network; feedback on the charging state for the devices being recharges; an interface for viewing, adding, deleting, or modifying the data on a drug dispensing device or FOB; a means for synchronizing data between multiple drug dispensing devices and/or FOBs; a means for updating a drug dispensing device; and a means for conducting a diagnostic test on drug dispensing devices and/or FOBs. [0085] A drug dispensing device may communicate with a physician or care giver, via a base station, dock or a wired or wireless communication means.
[0086] The dispensing device may employ one or more levels of interface for different types of authorized users, for example the patient, the nurse, the physician, pharmacist or other authorized medical or healthcare personnel. These different interfaces may include components such as keypads, buttons, graphical icons and instructions, lights, LED's, monochrome or color graphical or text displays, touch-screens, LCD's, sounds, tactile feedback, voice recognition interfaces, and other input and output devices and means. The activity, or mode, of the user interface may be determined by the mode of operation of the dispensing device, by a login or access activity by a user such as a password or code entry,
by the connection or disconnection of the dispensing device from a dock, computer, or network, or by the detection of an authorized access key, such as a key, and/or RFID tag, combination, password, barcode, or similar technology. Upon changing the interface mode, the functionality of the device may be changed, either activating, inactivating or changing the functionality of the various interface components described above. By allowing the device to have one or more interface modes, with differing functionality associated with each one, the device can be optimized for various uses. Single Dose Applicators (SDAs) and Multiple Dose Dispensers (MDDs) [0087] The invention further provides dispensing devices and methods of using the same for oral transmucosal delivery of a drug dosage form using a single dose applicator (SDA). Use of the SDA is not limited to any particular type of device or patient population. As such, the claimed SDAs find utility in drug delivery to pediatric, adult and non-human mammalian subjects.
[0088] In one embodiment, a SDA is used to administer a variety of drug dosage forms, including a solid tablet, a liquid capsule, a gel capsule, a liquid, a gel, a powder, a film, a strip, a ribbon, a spray, a mist, a patch, or any other suitable drug dosage form. [0089] The SDA may be provided as a pair of forceps, a syringe, a stick or rod, a straw, a pad, a capsule, a cup, a spoon, a strip, a tube, an applicator, a dropper, a patch, an adhesive pad, an adhesive film, a sprayer, an atomizer, or any other form suitable for the application of a single drug dosage form to the oral mucosa of a subject, e.g., the oral mucosa in the sublingual space. As will be understood by one of skill in the art, the SDA design may vary, so long as it is effective to place a drug dosage form, such as a tablet, in the desired location on an oral mucosal membrane, e.g., in the sublingual space, in a manner that preserves integrity of the drug dosage form in the dispensing process. After use, the SDA is disposed of, so as to eliminate the risk of contaminating the drug dispensing device with saliva, or other contaminants.
[0090] The SDA may contain the dosage form within, may have the drug dosage form attached or affixed to it, may have the dosage form dissolved in it, and may afford a seal against moisture, humidity, and light. The SDA may be manually manipulated by a patient, healthcare provider, or other user to place the dosage form in the proper location for drug delivery. The SDA may also be child resistant and/or enable abuse deterrence. [0091] The single-dose applicator is used to deliver tablets or other dosage forms into the hand, the mouth, under the tongue, or to other locations appropriate for specific drug delivery needs.
[0092] In one preferred embodiment, a single-dose applicator or drug dispensing device is used to deliver a dosage form directly to the oral mucosa, e.g., the sublingual space.
[0093] The dosage form inside the SDA remains dry prior to dispensing, at which point a single dosage form is dispensed onto the oral mucosa, and the patient's saliva wets the tablet and allows for tablet disintegration/erosion and drug dissolution. After use, the SDA is disposed of.
[0094] In one approach, for sublingual administration, a small volume dosage form is administered by placement under the tongue, adjacent to the frenulum with a syringe, a syringe-type SDA, a stick or rod, a straw, a dropper, or any other form suitable for the application of a single drug dosage form, including but not limited to a SDA. Numerous examples of SDAs are described in U.S. Patent Application Serial No. 12/187,937 and PCT Publication No. WO2008/085765. Figures 7A and B provide detailed drawings of an exemplary SDA; Fig 7A is an exploded view and Fig 7B is an assembled view. The embodiment of the device shown in Figs. 7A and B consists of two case halves, 171 and 169, a pusher 165, and a label, 209. For assembly, the two case halves are snapped together and the label 209 is applied so that the tip 199 is not allowed to deflect while the label 209 is still in place, providing one level of child resistant packaging. The tablet 67 is placed in the cavity between the case halves 171 and 169, and the pusher 165 is snapped into place trapping the tablet inside of the assembly. In this configuration as shown in Fig. 7A, the snap feature on the pusher 201 keeps the pusher 165 from coming out of the assembly and the raised portion on the pusher 197 bares against the edge of the label 209 to keep the pusher from advancing the tablet 67 out of the tip 199 thus acting as an additional level of child resistant packaging. During use, the user first removes the label 209 from the assembly. In this configuration, while the label 209 is no longer present to resist advancement of the pusher 165, there is a small bridge feature 203 in one or both of the case halves to provide some resistance so that accidental pusher actuation does not occur. To dispense the tablet 67, a user places the tip of the SDA 199 sublingually and pushes on the back of the pusher 165 hard enough to overcome the strength of the bridge feature 203. At this time, the bridge feature 203 breaks away and the pusher advances flexing the tip of the SDA 199 open while advancing the tablet out of the device and into the sublingual space.
[0095] In one embodiment, the claimed drug dispensing device contains a plurality of SDAs, provided in a cartridge or individually packaged which is designed to dispense a
single SDA containing a single drug dosage form for use by the patient, healthcare provider, or user. The drug dispensing device may dispense single SDAs and comprise any of a number of the features described herein which are advantageous to safe and effective dispensing of single drug dosage forms.
[0096] A plurality of SDAs may be provided as a series of individual SDAs attached by a backing or housed in a multiple dose dispenser 137 or multiple dose storage unit. In some cases, SDAs 123 are stored in a multiple dose storage unit which may be referred to as a multiple single-dose dispenser (MSD) or multiple dose dispenser (MDD) 137. Exemplary MSDs or MDDs are shown in Figures 8A-B, 9A-C, lOA-C, and in U.S. Patent Application Serial No. 12/187,937 and PCT Publication No. WO2008/085765. In each embodiment for use in dispensing SDAs, the MSD or MDD may comprise a sensing means 205 for detecting when an SDA is removed from the device along with electronics capable of recording and storing information as to when the SDA is removed. The MSD or MDD 137 is designed to be child resistant. Figures 8A-B, 9A-C and lOA-C show a plurality of SDAs 123 in various exemplary MSD or MDD configurations 137. As shown in Fig. HA and HB, the MSD/MDD may comprise a port 207, which when plugged into a computer allows for the download of stored information. See e.g., Figures 8A-B, 9A-C and lOA-C, which illustrate exemplary multiple dose applicators 137 for delivering dispensing drug dosage forms, each individually packaged in a SDA 123.
Dosage Forms
[0100] The dispensing devices and SDAs described herein provide for single or repeated dispensing of individual (single) small volume drug dosage forms for oral transmucosal administration to a patient.
[0101] The term "small volume drug dosage form" or "small volume dosage form" is used herein with reference to a small volume dosage form or tablet that has a volume of less than lOOmcl and a mass of less than lOOmg, a volume of less than 30mcl and a mass of less than 30mg, or a volume of from about 3mcl to about 15mcl or a mass of from about 3mg to about 15mg,. More specifically, the dosage form has a mass of less than lOOmg, 90mg, 80mg, 70mg, 60mg, 50mg, 40mg, 30mg, 29mg, 28mg, 27mg, 26mg, 25mg, 24mg, 23mg, 22mg, 21mg, 20mg, 19mg, 18mg, 17mg, 16mg, 15mg, 14mg, 13mg, 12mg, llmg, lOmg, 9mg, 8mg, 7mg, 6mg or 5mg or a volume of less than lOOmcl, 90mcl, 80mcl, 70mcl, 60 mcl, 50mcl, 40mcl, 30mcl, 29 mcl, 28 mcl, 27mcl, 26mcl, 25mcl, 24mcl, 23mcl, 22mcl, 21mcl, 20mcl, 19mcl, 18mcl, 17mcl, 16mcl, 15mcl, 14mcl, 13mcl, 12mcl, llmcl,
lOmcl, 9mcl, 8mcl, 7mcl, 6mcl or 5mcl.
[0102] In one embodiment, when subjected to an in vitro dissolution test in a Type II
USP dissolution apparatus, about 75%, 80%, 85%, 90%, 95% or more of the total amount of sufentanil in the tablet is released within 8 or 10 minutes. In another embodiment, when subjected to an in vitro dissolution test in a Type II USP dissolution apparatus, about
75%, 80%, 85%, 90%, 95% or more of the total amount of sufentanil in the tablet is released within 12 minutes.
[0103] The "dosage forms" may be administered with a drug dispensing device or SDA, typically have bioadhesive characteristics and may form a hydrogel upon contact with an aqueous solution. The "small volume drug dosage form" or "small volume dosage form may be referred to as a "NanoTab™".
[0104] A dosage form delivered using the drug dispensing devices and SDAs described herein finds utility in oral transmucosal administration of any drug that can be absorbed via the transmucosal route and can benefit from this route of administration, for example if the drug is susceptible to GI or first-pass metabolism.
[0105] In one aspect, the device or SDA contains a dosage form comprising from about lmcg to lOmg of a drug, from about 2 meg to about 1 mg, from about 5mcg to about
200mcg of a drug or from about lOmcg to about lOOmcg of a drug. Typically the drug will be used for the treatment of pain.
[0106] In another aspect, the dosage from comprises an opioid selected from the group consisting of sufentanil, alfentanil, fentanyl, lofentanil, carfentanil, remifentanil, trefentanil, and mirfentanil.
[0107] In one exemplary embodiment, the claimed oral transmucosal drug dosage form contains from about 0.25 meg to about 200mcg of sufentanil, from about 5mcg to 150mcg of sufentanil, from about lOmcg to lOOmcg of sufentanil, or from about lOmcg to about
30mcg of sufentanil. Sufentanil may be provided as sufentanil citrate, sufentanil base, or a combination thereof.
Solid Sufentanil Dosaαe Forms
[0108] In general, small volume solid dosage forms containing from about 2mcg to about 200mcg of sufentanil may be used for oral transmucosal drug delivery. The dosage forms contain sufentanil, alone or in combination with another drug, e.g., a benzodiazepine such as triazolam.
[0109] The process for manufacture of solid dosage forms, e.g., tablets, pills, capsules,
strips, films, powders, lozenges, membranes, patches, film or other forms, comprising sufentanil, typically involves the use of an aqueous and/or organic solvent. [0110] The dosage forms comprise a formulation that is neither effervescent nor does it comprise an essentially water-free, ordered mixture of microparticles of drug adhered to the surface of carrier particles, where the carrier particles are substantially larger than the microparticles of drug.
[0111] Typical formulations for preparation of sufentanil-containing solid dosage forms and methods of making them are described in US Patent Publication Nos. 20070207207 and 20080166404. An exemplary formulation for use in making a sufentanil-containing solid dosage form is bioadhesive and comprises from about 0.04% to about 4% sufentanil, from about 0.08% to about 1.7% sufentanil or from abut 0.1% to about 2.0% sufentanil, e.g., about 0.04%, 0.08%, 0.1%, 0.2%, 2.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 0.55%, 0.6%, 0.65%, 0.7%, 0.75%, 0.8%, 0.85%, 0.9%, 0.95%, 1.0%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%, 1.6%, 1.7%, 1.8%, 1.9%, 2.0%, 2.2%, 2.2%, 2.4%, 2.5%, 2.6%, 2.8%, 3.0%, 3.2%, 3.5% or 4% sufentanil.
[0112] Numerous suitable nontoxic pharmaceutically acceptable carriers for use in sufentanil-containing solid dosage forms can be found in Remington's Pharmaceutical Sciences, 17th Edition, 1985.
Systems For Administration Of Dosage Forms To A Patient
[0113] In one exemplary embodiment, the present invention provides a system, comprising: (1) a dispensing device or SDA for administration of a drug dosage form to the oral mucosa of a subject, for example, a small-volume dosage form or NanoTab™; (2) a dosage form for oral transmucosal administration, such as a small-volume dosage form or
NanoTab™; and (3) a subject.
[0114] In another exemplary embodiment, the system for administration of dosage forms to a patient using the claimed drug dispensing device further includes a drug dispensing device wherein the dispensing device comprises a means for patient identification and/or a lock-out feature.
[0115] Additional features which may be included in the system includes a docking station or other docking means, a means of communication with a computer network such as a bidirectional communication link with a local or remote computer system (wired or wireless), a pharmaceutical network monitoring and control apparatus, a computer network that stores, records and transits information about drug delivery from the device and one
or more user interfaces.
Utility
[0116] Exemplary conditions treatable with the claimed dispensing devices and SDAs, include but are not limited to acute pain, post operative pain, cancer breakthrough pain, procedural pain and anxiety, nausea and/or vomiting.
[0117] One use for the claimed drug dispensing device arises in the inpatient setting. For example, the need for rapid treatment of acute pain occurs in many different clinical situations, including pain following an accident; post-operative pain; rheumatoid arthritis; back injury; cancer; etc. in the hospital setting. Post-operatively, for example, patients suffer from severe pain for the first few days followed by days of mild to moderate levels of pain.
[0118] In one embodiment of the invention, a cartridge for use in the device in the inpatient or outpatient setting may hold sufficient drug dosage forms for a single day or multiple 1-5 days of treatment, e.g., 40 tablets useful for up to 48 hours of treatment. [0119] In another embodiment the drug dispensing device is comprised of a disposable drug cartridge, a disposable dispensing end, a reusable controller end, a user identification means like an RFID tag, a portable docking FOB for controlling and accessing the drug dispensing device, and a base station for recharging the reusable dispensing end and the portable docking FOB. In this embodiment the drug cartridge is loaded into the disposable dispensing end, which, in turn, is connected to the reusable controller end and affixed together. This assembly completes the drug dispensing device which is capable of dispensing dosage forms to the patient upon request, providing a lockout period between dosing, recording dosing and usage history, and allowing this history and the drug dispensing device settings to be reviewed or electronically downloaded. An RFID tag would be affixed to a patient so as to provide a wireless identification means that would enable the drug dispensing device to operate properly when in proximity to the correct RFID tag. A healthcare provider could use the portable docking FOB to dock with the drug dispensing device, allowing access to settings, controls, history, and other features. When not in use, the reusable controller end and the portable docking FOB could be placed in the base station to recharge the batteries or power supply.
[0120] In yet another embodiment, the drug dispensing device comprises a disposable drug cartridge containing 40 tablets and useful for up to 48 hours of treatment, a disposable dispensing end, a reusable controller end, a user identification means like a
directional RFID tag, a lockout feature (e.g., with a set lockout time of 20 minutes) and a base station for recharging the reusable dispensing end. In this embodiment, the controller contains a user interface that can be used to upload data from the device, download data such as dosing history or the number of tablets remaining in the cartridge, control access to the drug dispensing device, control access to the drug dosage forms, control access to a tether or other connectable apparatus, and communicate bidirectionally with a hospital computer system or other computer network by means of a wired or wireless connection. In this embodiment, the drug cartridge is loaded into the disposable dispensing end, which, in turn, is connected to the reusable controller end and affixed together and the dispensing end and cartridge are disposable. When outside the lockout window, the drug dispensing device is capable of dispensing dosage forms to a patient upon request when the patient pushes a "dispense button". The dispensing device can record dosing and usage information, and is capable of allowing the information and the drug dispensing device settings to be reviewed or electronically downloaded. In one approach, a directional RFID tag is affixed to the patient so as to provide a wireless identification means that would enable the drug dispensing device to operate properly when in proximity to the correct RFID tag. In other approaches, a different patient identification means such as fingerprint matching is employed. In either case, a healthcare provider interacts directly with the controller end to adjust settings, controls, download usage information, etc. When not in use, the reusable controller end is placed in the base station to recharge the batteries.
[0121] When used in the inpatient setting, the claimed dispensing device offers several features and advantages over the state of the art in patient drug administration. The dispensing device allows healthcare providers to provide drug dosage forms to a patient for self administration of PRN ("Pro Re Nata") medications. PRN refers to drugs that are taken as needed, such as for pain, nausea, constipation, anxiety, etc. The claimed drug dispensing device may be used to dispense any PRN medication in any drug dosage form in the inpatient setting affording any combination of the features set forth above, as described in U.S. Patent Publication No. 20070299687.
[0122] In another embodiment, a MSD comprising thirty (30) SDAs is prescribed for a patient who is subjected to an outpatient surgical procedure at a clinic. The patient self administers the first drug dosage form with the assistance of a caregiver while at the clinic, then takes the MSD home for self administration of one or more doses of the drug. [0123] The claimed dispensing device may also be used in the outpatient setting or in
both the inpatient and outpatient setting, e.g., for treatment of post operative pain or cancer breakthrough pain. Further examples of outpatient indications where the claimed dispensing device finds utility include pain associated with physical trauma, chronic pain, chronic breakthrough pain, anxiety, insomnia, hypertension, coronary artery disease, depression, psychosis, addiction, ADHD, high blood pressure, diabetes, constipation, nausea, vertigo and others. See, e.g., U.S. Patent Publication No. 20070260491 [0124] To effectively assist in the dispensing of drugs in the acute outpatient setting, the dispensing device may provide some or all of the following features: allow the patient to self administer the medication; record dosing history; allow the dosing history to be read or transferred to a computer, network or other electronic device; deter tampering or diversion; have child safety; have lockout; deliver the drug dosage form to the appropriate location (e.g. sublingual, or buccal); record a dosing administration or a temperature or humidity event.
[0125] When used in the outpatient acute setting (home, office, field, etc.), the dispensing device offers several features and advantages over the state of the art in outpatient drug administration. The dispensing device allows individuals to self administer drugs in accordance with physician, healthcare provider, or drug label guidelines. The drug dispensing devices, SDAs, methods and systems described herein find utility in this setting. A patient may transition from the inpatient environment where a drug dosage form is delivered using the dispensing device (e.g., as shown in Figs. 1-2 and 4-6) to the outpatient setting where the same drug dosage form is administered using an SDA/MSD (e.g., as shown as in Figs. 7-10). This allows a patient to move from the inpatient to the outpatient setting without having to switch medications.
[0126] The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the invention is not entitled to antedate such a disclosure by virtue of prior invention.
[0127] Although the foregoing has been described in some detail by way of illustration and example for purposes of clarity and understanding, it will be apparent to those skilled in the art that certain changes and modifications may be practiced. Various aspects of the invention have been achieved by a series of experiments, some of which are described by way of the following non-limiting examples. Therefore, the description and examples should not be construed as limiting the scope of the invention, which is delineated by the appended description of exemplary embodiments.
Claims
1. A radio frequency identification (RFID) system for patient identification, comprising:
(a) a handheld device having an RFID reader antenna; and
(b) a matching wrist worn RFID tag or inlay consisting essentially of a die or chip, a circuit and an antenna, wherein the antenna comprises annular conductors that circumvent the wrist and the antenna field has an axis directed at the patient's hand, and said patient identification occurs when a handheld device comprising the reader antenna is held in the patient's hand, whereby the reader antenna is activated.
2. The RFID system according to Claim 1, wherein said wrist worn RFID tag is a bracelet.
3. The RFID system according to Claim 1 or 2, wherein said RFID signal is directional and symmetrical.
4. The RFID system according to any one of Claims 1 to 3, wherein the distance between said handheld device and said wrist worn RFID tag or inlay, is selected from the group of distances consisting of between 0 inches and 12 inches, between 0 and 8 inches, and between 0 and 6 inches.
5. The drug dispensing system according to any one of Claims 1 to 4, wherein when the wrist worn RFID tag is removed, the RFID tag or inlay is damaged or destroyed and the drug dispensing system becomes non-functional.
6. The drug dispensing system according to Claim 5, further comprising a sufentanil- containing drug dosage form.
7. A method for controlled access to a drug by a patient, comprising: providing a drug dispensing device comprising the RFID system for patient identification according to any one of Claims 1 to 4, said dispensing device further comprising small volume drug dosage forms and a timed lock-out feature, said timed lockout feature providing for a set lock-out time, wherein said dispensing device is activated and dispenses a drug dosage form following patient identification when said set lock-out time has passed.
8. A system for safe administration of sufentanil to an oral mucosal membrane of a subject in the outpatient setting, comprising: a multiple single-dose dispenser (MSD) containing a plurality of single dose applicators (SDAs) each SDA comprising a drug dosage form with an amount of sufentanil selected from the group consisting of 5mcg, lOmcg, 15mcg, 20mcg, 30mcg, 40mcg, 50mcg, 60mcg, 70mcg, 80mcg and lOOmcg, wherein said drug dosage forms have a volume of less than 30 microliters or a mass of less than 30mg.
9. The system according to Claim 8, wherein said oral transmucosal membrane is a sublingual membrane.
10. The system according to Claim 8 or 9, wherein said MSD comprises a lock-out feature adapted for setting a lock-out time and an SDA cannot be removed from said MSD during said lock-out time.
11. The system according to any one of Claims 8 to 10, wherein said MSD comprises a dose counting feature.
12. The system according to any one of Claims 8 to 11, wherein said MSD comprises a patient identification feature.
13. The system according to Claim 12, wherein said patient identification feature is RFID.
14. The system according to any one of Claims 8 to 13, wherein said MSD has a child resistant feature.
15. A method for controlled access to a drug by a patient, comprising: providing a multiple single-dose dispenser (MSD) system containing a plurality of single dose applicators (SDAs) according to any one of Claims 8 to 14, said MSD further comprising a timed lock-out feature, said timed lock-out feature providing for a set lock-out time, wherein said MSD is activated and dispenses an SDA following patient identification when said set lock-out time has passed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16126709P | 2009-03-18 | 2009-03-18 | |
US61/161,267 | 2009-03-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010107761A1 true WO2010107761A1 (en) | 2010-09-23 |
Family
ID=42226622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/027437 WO2010107761A1 (en) | 2009-03-18 | 2010-03-16 | Improved storage and dispensing devices for administration of oral transmucosal dosage forms |
Country Status (2)
Country | Link |
---|---|
US (7) | US8548623B2 (en) |
WO (1) | WO2010107761A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103315815A (en) * | 2013-06-25 | 2013-09-25 | 四川品杰科技有限公司 | RFID (radiofrequency identification) wrist strap |
WO2014199374A1 (en) * | 2013-06-09 | 2014-12-18 | Vaica Medical Ltd. | Automated medication dispensing and related applications thereof |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
US9289583B2 (en) | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US9066847B2 (en) | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
US8202535B2 (en) | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8252329B2 (en) | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
EP3269346A1 (en) * | 2007-08-07 | 2018-01-17 | Acelrx Pharmaceuticals, Inc. | Apparatus for oral drug delivery |
US8945592B2 (en) * | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
WO2010107761A1 (en) * | 2009-03-18 | 2010-09-23 | Acelrx Pharmaceuticals, Inc. | Improved storage and dispensing devices for administration of oral transmucosal dosage forms |
US20110091544A1 (en) * | 2009-10-16 | 2011-04-21 | Acelrx Pharmaceuticals, Inc. | Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
EP2572302B1 (en) | 2010-05-19 | 2021-02-17 | Sanofi-Aventis Deutschland GmbH | Modification of operational data of an interaction and/or instruction determination process |
BR112013003331A2 (en) | 2010-08-13 | 2017-07-11 | l kraft Daniel | systems and methods for the production of custom drug products |
EP3603704B1 (en) * | 2010-12-17 | 2023-04-26 | Sanofi-Aventis Deutschland GmbH | Medicament administration |
US20120192862A1 (en) * | 2011-01-31 | 2012-08-02 | Carefusion 303, Inc. | Patient-controlled aerosol administration |
US20130057392A1 (en) * | 2011-03-14 | 2013-03-07 | Roddy M. Bullock | Method and System for Disabling an Electronic Device |
US10265245B2 (en) * | 2011-08-27 | 2019-04-23 | Daniel L. Kraft | Portable drug dispenser |
CN104379112B (en) * | 2012-04-20 | 2018-01-30 | 史密斯医疗Asd公司 | Pill dispenser |
AT513089A1 (en) * | 2012-06-22 | 2014-01-15 | Mkw Electronics Gmbh | Method for recording data |
US20140043162A1 (en) * | 2012-08-13 | 2014-02-13 | Michael Siciliano | Inventory system for the prevention of tobacco product theft |
US9313609B2 (en) * | 2012-12-28 | 2016-04-12 | Joseph Nicholi Prencipe | Contact information social exchange method and system |
US10572700B2 (en) | 2013-06-26 | 2020-02-25 | Vypin, LLC | Wireless asset location tracking system and related techniques |
US9904885B2 (en) * | 2014-04-06 | 2018-02-27 | Vypin, LLC | Wireless medication compliance sensing device, system, and related methods |
US10121028B2 (en) | 2013-06-26 | 2018-11-06 | Vypin, LLC | Asset tag apparatus and related methods |
US20150039124A1 (en) * | 2013-07-30 | 2015-02-05 | Ronald Justin Mistovich | Automatic Medication Compliance Dispenser System And Method |
US20150122252A1 (en) * | 2013-11-01 | 2015-05-07 | Kevin FRIJA | Hand-held personal vaporizer |
US9272123B2 (en) * | 2013-12-16 | 2016-03-01 | Esther Gallant | Device and method for inserting lubricating capsule |
JP6817074B2 (en) | 2014-06-03 | 2021-01-20 | アムジエン・インコーポレーテツド | Controllable drug delivery system and usage |
CA2955783A1 (en) | 2014-07-21 | 2016-01-28 | Smiths Medical Asd, Inc. | Dose request systems and methods |
US11357916B2 (en) | 2014-12-19 | 2022-06-14 | Amgen Inc. | Drug delivery device with live button or user interface field |
EP3233163B1 (en) | 2014-12-19 | 2021-10-13 | Amgen Inc. | Drug delivery device with proximity sensor |
AU2015369710B2 (en) | 2014-12-23 | 2020-09-17 | Vertical Pharmaceuticals, Llc | Systems, devices and methods for dispensing oral transmucosal dosage forms |
WO2016127051A1 (en) | 2015-02-05 | 2016-08-11 | Aasc Dispenser, Llc | Rotary pill dispenser and method of use |
KR101667192B1 (en) * | 2015-02-27 | 2016-10-18 | (주)이화바이오메딕스 | Liquid medicine infuser and liquid medicine supply device including the same |
CA2983872C (en) * | 2015-05-07 | 2023-06-20 | Smart Wave Technologies Corp. | Signal and detection system for pairing products |
US9450306B1 (en) * | 2015-05-07 | 2016-09-20 | Nxp B.V. | Antenna for wireless communications |
JP5937726B1 (en) * | 2015-05-12 | 2016-06-22 | 善郎 水野 | Sensor management system |
US10001415B2 (en) | 2015-08-11 | 2018-06-19 | General Electric Company | Multifunctional sensor |
CN108367105B (en) | 2015-10-30 | 2021-04-16 | 阿塞尔Rx制药有限公司 | Apparatus and method for dispensing oral transmucosal dosage forms |
JP6651812B2 (en) * | 2015-11-25 | 2020-02-19 | カシオ計算機株式会社 | Throwing detection system, method, pattern detection device, pattern generation device, and flying device provided with pattern detection device |
US11083837B2 (en) | 2016-03-22 | 2021-08-10 | International Business Machines Corporation | Secure medication delivery |
US10376444B2 (en) | 2016-03-22 | 2019-08-13 | International Business Machines Corporation | Secure medication delivery |
FR3052086B1 (en) * | 2016-06-07 | 2018-06-15 | Louis Vuitton Malletier | SYSTEM FOR TESTING A FRAGRANCE |
US10292906B1 (en) * | 2016-06-21 | 2019-05-21 | Daniel Gershoni | Contactless automatic pill dispenser with blister-pack support |
US10675221B2 (en) * | 2016-07-26 | 2020-06-09 | The Regents Of The University Of California | Systems and methods for controlling and monitoring medication dispensation |
US9731103B1 (en) | 2017-01-13 | 2017-08-15 | Berkshire Biomedical, LLC | Computerized oral prescription administration devices and associated systems and methods |
US10792226B2 (en) | 2017-06-07 | 2020-10-06 | Berkshire Biomedical, LLC | Refill and dosage management devices and associated systems and methods for use with computerized oral prescription administration devices |
US11464710B2 (en) * | 2017-09-14 | 2022-10-11 | Tupelolife Services, Llc | Automated and secure methods for dispensing medication |
US10575988B2 (en) | 2017-10-12 | 2020-03-03 | Amo Development, Llc | Ophthalmic docking system with 3-dimensional automatic positioning using differential RF coupling |
US10568765B2 (en) | 2017-10-17 | 2020-02-25 | Amo Development, Llc | Ophthalmic docking system with 3-dimensional automatic positioning using magnetic sensing array |
US10441509B2 (en) | 2018-03-16 | 2019-10-15 | Berkshire Biomedical, LLC | Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods |
US10505394B2 (en) * | 2018-04-21 | 2019-12-10 | Tectus Corporation | Power generation necklaces that mitigate energy absorption in the human body |
US10834112B2 (en) * | 2018-04-24 | 2020-11-10 | At&T Intellectual Property I, L.P. | Web page spectroscopy |
US10895762B2 (en) | 2018-04-30 | 2021-01-19 | Tectus Corporation | Multi-coil field generation in an electronic contact lens system |
US10838239B2 (en) | 2018-04-30 | 2020-11-17 | Tectus Corporation | Multi-coil field generation in an electronic contact lens system |
US10790700B2 (en) | 2018-05-18 | 2020-09-29 | Tectus Corporation | Power generation necklaces with field shaping systems |
US11137622B2 (en) | 2018-07-15 | 2021-10-05 | Tectus Corporation | Eye-mounted displays including embedded conductive coils |
US11311460B1 (en) | 2018-08-08 | 2022-04-26 | Telemedicine Health, Inc. | Method and apparatus of secure storage for dispensing of opioids (SSDO) |
US11854680B1 (en) | 2018-08-08 | 2023-12-26 | Telemedicine Health, Inc. | Narcotics and opioids secure storage and dispensing apparatus and method of use |
US11450420B2 (en) * | 2018-08-21 | 2022-09-20 | Vivera Pharmaceuticals Inc. | Secure smart dosing system with automated delivery, measurement, and management for pills |
US10838232B2 (en) | 2018-11-26 | 2020-11-17 | Tectus Corporation | Eye-mounted displays including embedded solenoids |
US10644543B1 (en) | 2018-12-20 | 2020-05-05 | Tectus Corporation | Eye-mounted display system including a head wearable object |
US10729860B1 (en) | 2019-05-22 | 2020-08-04 | Berkshire Biomedical, LLC | Computerized oral prescription administration for securely dispensing a medication and associated systems and methods |
US10944290B2 (en) | 2019-08-02 | 2021-03-09 | Tectus Corporation | Headgear providing inductive coupling to a contact lens |
US20230414400A1 (en) * | 2021-05-05 | 2023-12-28 | Kinan Muhsin Salloum | Thumb sucking deterrent system |
WO2023196316A1 (en) | 2022-04-04 | 2023-10-12 | Zig Therapeutics, Inc. | Medication storage and closure container, medication delivery station for delivery of medication from a replaceable pre- filled medication storage and closure container, automated and adaptable remote medication management system including a medication delivery station, and methods of operating and/or utilizing the same |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030173408A1 (en) * | 2002-03-18 | 2003-09-18 | Precision Dynamics Corporation | Enhanced identification appliance |
WO2007081947A2 (en) | 2006-01-06 | 2007-07-19 | Acelrx Pharmaceuticals, Inc. | Drug storage and dispensing devices and systems comprising the same |
US20070207207A1 (en) | 2006-01-06 | 2007-09-06 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US20070260491A1 (en) | 2006-05-08 | 2007-11-08 | Pamela Palmer | System for delivery and monitoring of administration of controlled substances |
US20070299687A1 (en) | 2006-06-23 | 2007-12-27 | Pamela Palmer | Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed |
US20080166404A1 (en) | 2007-01-05 | 2008-07-10 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US20080164275A1 (en) | 2007-01-05 | 2008-07-10 | Acelrx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
WO2008085764A1 (en) | 2007-01-05 | 2008-07-17 | Acelrx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
WO2008085765A2 (en) | 2007-01-05 | 2008-07-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US20080203107A1 (en) * | 2001-09-19 | 2008-08-28 | Conley N Sharon | Patient controlled timed medication dispenser |
Family Cites Families (200)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2621655A (en) | 1951-10-11 | 1952-12-16 | Kenneth L Gothard | Tablet dispensing gun |
US3162322A (en) * | 1962-03-29 | 1964-12-22 | John E Gilbertson | Sanitary dispenser for cartridges holding fluid medicants |
US3238941A (en) | 1963-06-19 | 1966-03-08 | Frost Eng Dev | Balling gun |
GB1142325A (en) | 1965-05-14 | 1969-02-05 | Higham Stanley Russell | Means for administering drugs |
US3757781A (en) | 1971-09-17 | 1973-09-11 | R Smart | Tool for administering pills to animals |
US3780735A (en) * | 1972-02-03 | 1973-12-25 | J Crouter | Dose syringe |
US3789845A (en) | 1973-01-29 | 1974-02-05 | J Long | Capsule and tablet administration for animals |
FR2278317A1 (en) | 1974-07-19 | 1976-02-13 | Commissariat Energie Atomique | ORAL IMPLANT FOR ADMINISTERING SOLUBILIZABLE PRODUCTS |
US4060083A (en) | 1976-04-01 | 1977-11-29 | Hanson Raymond L | Pill gun |
MX146241A (en) | 1976-09-30 | 1982-06-02 | Antonio Lorca Vera | IMPROVEMENTS TO PACKAGE TO SUPPLY PILLS AND SIMILAR |
US4900303A (en) * | 1978-03-10 | 1990-02-13 | Lemelson Jerome H | Dispensing catheter and method |
US4237884A (en) | 1978-03-17 | 1980-12-09 | Victor Erickson | Medication dispenser |
US4465191A (en) | 1982-06-14 | 1984-08-14 | Darbo Rolf E | Personal tablet dispenser |
US4474308A (en) * | 1982-09-30 | 1984-10-02 | Michel Bergeron | Tablet ejector |
US4489853A (en) | 1982-12-15 | 1984-12-25 | Korte Jay S | Pill dispensing device |
US4614366A (en) * | 1983-11-18 | 1986-09-30 | Exactident, Inc. | Nail identification wafer |
GB8332556D0 (en) | 1983-12-06 | 1984-01-11 | Reckitt & Colmann Prod Ltd | Analgesic compositions |
US4863737A (en) | 1985-05-01 | 1989-09-05 | University Of Utah | Compositions and methods of manufacture of compressed powder medicaments |
US4769011A (en) | 1985-03-28 | 1988-09-06 | Interpore International, Inc. | Syringe apparatus and method for the surgical implantation of granular substances |
US4764378A (en) | 1986-02-10 | 1988-08-16 | Zetachron, Inc. | Buccal drug dosage form |
US4733797A (en) | 1986-09-22 | 1988-03-29 | Haber Terry M | Dosage sealing, monitoring and dispensing assembly |
DE3632546A1 (en) | 1986-09-25 | 1988-03-31 | Knoll Ag | DOSAGE DISPENSER |
US4785969A (en) | 1986-11-10 | 1988-11-22 | Pyxis Corporation | Medication dispensing system |
DE3855054T2 (en) | 1987-05-26 | 1996-07-18 | Sumitomo Pharma | Device for the administration of solid preparations |
IT1233374B (en) | 1988-12-21 | 1992-03-27 | Mccarthy Martin M | DISPOSABLE SYRINGE FOR PERCUTANEOUS INJECTIONS |
AT391300B (en) | 1989-04-12 | 1990-09-10 | Hinterreiter Ignaz | TABLET DISPENSER |
US5110008A (en) | 1989-09-29 | 1992-05-05 | Moulding Jr Thomas S | Dispenser adapted to isolate the dispensed objects by compression between two moveable structures |
US5190185A (en) * | 1990-05-18 | 1993-03-02 | Baxter International Inc. | Medication transport and dispensing magazine |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
US5296234A (en) | 1991-10-11 | 1994-03-22 | Abbott Laboratories | Holder and packaging for a hardened medicated matrix |
US5263596A (en) * | 1991-12-02 | 1993-11-23 | Williams David R | Medication dispenser station sub-assembly |
US5348158A (en) | 1991-12-19 | 1994-09-20 | G. D. Searle & Co. | Dispenser pack for the successive dispensing of a drug |
NL9200844A (en) | 1992-05-13 | 1993-12-01 | De Wijdeven Gijsbertus G P Van | DEVICE AND METHOD FOR INJECTING WITH A SOLID SUBSTANCE. |
US5292307A (en) | 1992-09-16 | 1994-03-08 | Dolzine Theodore W | Dispensing package for unit dosage |
US5380295A (en) | 1992-12-14 | 1995-01-10 | Mallinckrodt Medical, Inc. | Delivery apparatus with mechanism preventing rearward movement of a piston disposed therein |
US5507277A (en) | 1993-01-29 | 1996-04-16 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activateddispenser |
US5724957A (en) | 1993-01-29 | 1998-03-10 | Aradigm Corporation | Intrapulmonary delivery of narcotics |
US5694919A (en) | 1993-01-29 | 1997-12-09 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activated dispenser |
US5304119A (en) * | 1993-06-24 | 1994-04-19 | Monsanto Company | Instrument for injecting implants through animal hide |
US5366113A (en) | 1993-12-13 | 1994-11-22 | Kim David S | Pill dispenser |
US5540665A (en) | 1994-01-31 | 1996-07-30 | Alza Corporation | Gas driven dispensing device and gas generating engine therefor |
US5507807A (en) * | 1994-03-01 | 1996-04-16 | Shippert; Ronald D. | Apparatus for the release of a substance within a patient |
US5489025A (en) | 1994-03-01 | 1996-02-06 | Romick; Jerome M. | Unit-dose medication dispenser and multiple-dispenser frame therefor |
US5581484A (en) * | 1994-06-27 | 1996-12-03 | Prince; Kevin R. | Finger mounted computer input device |
US6685013B2 (en) | 1994-07-13 | 2004-02-03 | Centrix, Inc. | Single patient dose medicament dispenser with applicator |
US6328159B1 (en) | 1994-07-13 | 2001-12-11 | Centrix, Inc | Single patient dose medicament dispenser with applicator |
US5660273A (en) | 1994-07-13 | 1997-08-26 | Centrix, Inc. | Single patient dose medicament dispenser with applicator |
JPH10505764A (en) | 1994-09-16 | 1998-06-09 | ラボラトワール、グラクソ、ウェルカム | Inhaler |
US5584805A (en) | 1995-03-17 | 1996-12-17 | Sutton; Matthew R. | Animal pill-dispenser gun |
US6881208B1 (en) | 1995-06-05 | 2005-04-19 | Joseph B. Phipps | Method and device for transdermal electrotransport delivery of fentanyl and sufentanil |
CN1147329C (en) | 1995-06-05 | 2004-04-28 | 阿尔萨公司 | Device for trandermal electrotransport delivery of fentanyl and sufentanil |
US6216033B1 (en) | 1996-05-22 | 2001-04-10 | Alza Corporation | Device for transdermal electrotransport delivery of fentanyl and sufentanil |
US6605060B1 (en) | 1995-06-07 | 2003-08-12 | O'neil Alexander George Brian | Patient controlled drug delivery device |
US5984888A (en) | 1995-06-07 | 1999-11-16 | Kimberly-Clark Worldwide, Inc. | Applicator and coating |
US5710551A (en) | 1995-07-26 | 1998-01-20 | Ridgeway; Donald G. | Self-medication monitoring system |
AUPN603895A0 (en) | 1995-10-19 | 1995-11-09 | University Of Queensland, The | Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids |
JPH09193974A (en) | 1996-01-19 | 1997-07-29 | Yoshino Kogyosho Co Ltd | Tablet housing container |
US5646912A (en) | 1996-01-25 | 1997-07-08 | Cousin; Damon S. | Medication compliance, co-ordination and dispensing system |
GB2309966A (en) | 1996-02-07 | 1997-08-13 | Harwill Ind Pty Ltd | Teat device for administering medicaments |
US5995938A (en) | 1996-02-27 | 1999-11-30 | Whaley; Susan S. | Medication compliance system |
US5827293A (en) * | 1996-05-13 | 1998-10-27 | Elliott; James B. | Subcutaneous insertion device |
US6530896B1 (en) | 1996-05-13 | 2003-03-11 | James B. Elliott | Apparatus and method for introducing an implant |
AU3254397A (en) | 1996-07-05 | 1998-02-02 | Novo Nordisk A/S | Instrument for inserting a suppository |
NL1003596C2 (en) | 1996-07-15 | 1997-05-27 | Cons Health Entrepreneurs Bv | Vending machine dispenser. |
US5954641A (en) | 1997-09-08 | 1999-09-21 | Informedix, Inc. | Method, apparatus and operating system for managing the administration of medication and medical treatment regimens |
US5752620A (en) | 1996-11-13 | 1998-05-19 | Pearson Ventures, L.L.C. | Medication dispenser |
US6529446B1 (en) | 1996-12-20 | 2003-03-04 | Telaric L.L.C. | Interactive medication container |
US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
US5950632A (en) | 1997-03-03 | 1999-09-14 | Motorola, Inc. | Medical communication apparatus, system, and method |
US8391104B2 (en) | 1997-03-28 | 2013-03-05 | Carlos De La Huerga | Interactive medication container labeling |
US5945651A (en) | 1997-07-17 | 1999-08-31 | Chorosinski; Leonard | Remotely programmable medication dispensing system |
US5850937A (en) | 1997-08-14 | 1998-12-22 | Rauche; Stephen J. | Dispenser with means for alerting a user |
US6660295B2 (en) | 1997-09-30 | 2003-12-09 | Alza Corporation | Transdermal drug delivery device package with improved drug stability |
WO2000066458A1 (en) | 1997-10-30 | 2000-11-09 | HALLIN, Cristian under the firm of TELUM PRODUCTI N | A tablet dispenser |
US5997518A (en) | 1998-01-14 | 1999-12-07 | Laibovitz; Robert A. | Apparatus and method for delivery of small volumes of liquid |
WO1999042800A1 (en) * | 1998-02-20 | 1999-08-26 | Massachusetts Institute Of Technology | Finger touch sensors and virtual switch panels |
US6039251A (en) | 1998-04-16 | 2000-03-21 | Holowko; Paul L. | Method and system for secure control of a medical device |
DE69928267T2 (en) | 1998-08-28 | 2006-06-08 | Glaxo Group Ltd., Greenford | DONOR |
JP2000142841A (en) | 1998-11-17 | 2000-05-23 | Lion Corp | Container for small-sized article |
JP3459882B2 (en) | 1998-11-30 | 2003-10-27 | 株式会社バンダイ | Article removal device |
FR2788040B1 (en) | 1998-12-31 | 2001-03-23 | Airsec Sa | DISTRIBUTOR OF OBJECTS |
US6131765A (en) | 1999-01-08 | 2000-10-17 | Barry; William Dean | Device for storing and dispensing solid-form medication |
AU2879100A (en) | 1999-02-12 | 2000-08-29 | Miles A. Libbey Iii | Formulation and system for intra-oral delivery of pharmaceutical agents |
US6835194B2 (en) | 1999-03-18 | 2004-12-28 | Durect Corporation | Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
US6541021B1 (en) | 1999-03-18 | 2003-04-01 | Durect Corporation | Devices and methods for pain management |
US6601729B1 (en) | 1999-03-26 | 2003-08-05 | Papp Enterprises, Llc | Automated portable medication radial dispensing apparatus and method using a carrier tape |
US6234343B1 (en) | 1999-03-26 | 2001-05-22 | Papp Enterprises, Llc | Automated portable medication radial dispensing apparatus and method |
US6762684B1 (en) | 1999-04-19 | 2004-07-13 | Accutrak Systems, Inc. | Monitoring system |
US6319510B1 (en) | 1999-04-20 | 2001-11-20 | Alayne Yates | Gum pad for delivery of medication to mucosal tissues |
US6190326B1 (en) | 1999-04-23 | 2001-02-20 | Medtrac Technologies, Inc. | Method and apparatus for obtaining patient respiratory data |
EP1214118B2 (en) | 1999-04-29 | 2013-11-27 | Peter James Brian Lamb | Device for depositing a non-flowable object or a non-flowable medicament in a vagina |
GB9911388D0 (en) | 1999-05-18 | 1999-07-14 | Glaxo Group Ltd | Dispenser |
US6258056B1 (en) | 1999-06-10 | 2001-07-10 | Mark L. Anderson | Implanter apparatus |
US6382204B1 (en) | 1999-10-14 | 2002-05-07 | Becton Dickinson And Company | Drug delivery system including holder and drug container |
RU2155015C1 (en) | 1999-11-23 | 2000-08-27 | Федеральное государственное унитарное предприятие Конструкторское бюро химавтоматики | Pneumatic injector without needle |
PE20010720A1 (en) | 1999-12-11 | 2001-07-26 | Glaxo Group Ltd | MEDICATION DISTRIBUTOR |
US6294999B1 (en) | 1999-12-29 | 2001-09-25 | Becton, Dickinson And Company | Systems and methods for monitoring patient compliance with medication regimens |
US6471645B1 (en) | 1999-12-30 | 2002-10-29 | Medtronic, Inc. | Communications system for an implantable device and a drug dispenser |
GB0004456D0 (en) | 2000-02-26 | 2000-04-19 | Glaxo Group Ltd | Medicament dispenser |
AU3400501A (en) | 2000-02-28 | 2001-09-12 | Vectura Ltd | Improvements in or relating to the delivery of oral drugs |
US6943665B2 (en) * | 2000-03-21 | 2005-09-13 | T. Eric Chornenky | Human machine interface |
US6364158B1 (en) * | 2000-03-24 | 2002-04-02 | John Dimoulis | Anesthetic dispensing station and method of using same |
WO2002011778A1 (en) | 2000-05-10 | 2002-02-14 | University Of Kentucky Research Foundation | System and method for intranasal administration of opioids |
AT409366B (en) | 2000-06-20 | 2002-07-25 | Haas Beteiligungsgesellschaft | Magazine for accommodating tablets and dispensing them individually |
AU2001274307A1 (en) | 2000-06-22 | 2002-01-02 | Pharmasol Ltd | Pharmaceutical compositions |
US20020026330A1 (en) | 2000-08-23 | 2002-02-28 | Klein Edward E. | System and method for patient medication management and compliance using a portable computing device |
US8454552B2 (en) * | 2000-08-24 | 2013-06-04 | Cardiac Science Corporation | Method for constructing an instrument with a covered bore for subcutaneous implantation |
GB2368061B (en) | 2000-10-20 | 2005-05-11 | Gw Pharmaceuticals Ltd | Dose dispensing apparatus |
US7465295B2 (en) | 2000-10-20 | 2008-12-16 | Bergeron Michel G | Applicator for the delivery of topical formulations into mucosal cavities |
US20050054942A1 (en) | 2002-01-22 | 2005-03-10 | Melker Richard J. | System and method for therapeutic drug monitoring |
JP4850346B2 (en) | 2001-03-15 | 2012-01-11 | 救急薬品工業株式会社 | Mucosal patch |
DE60205093T2 (en) | 2001-03-15 | 2006-05-24 | The Government of the United States of America, as represented by the Secretary, Centers for Disease Control and Prevention | BREAKER WITH COOLING CHAMBER |
GB0108228D0 (en) | 2001-04-02 | 2001-05-23 | Glaxo Group Ltd | Medicament dispenser |
GB0108215D0 (en) | 2001-04-02 | 2001-05-23 | Glaxo Group Ltd | Medicament dispenser |
US20030051728A1 (en) | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
DE60230035D1 (en) | 2001-05-24 | 2009-01-08 | Alexza Pharmaceuticals Inc | ADMINISTRATION OF ALPRAZOLAM, ESTAZOLAM, MIDAZOLAM OR TRIAZOLAM BY INHALATION |
US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
US6737042B2 (en) | 2001-05-24 | 2004-05-18 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
US6564967B1 (en) | 2001-06-29 | 2003-05-20 | Brown & Williamson Tobacco Corporation | Child resistant tablet dispenser |
US20030022910A1 (en) | 2001-07-05 | 2003-01-30 | R.T. Alamo Ventures I, Inc. | Compositions and methods for sublingual formulations of dihydroergotamine for the treatment of migraine |
US20030017175A1 (en) | 2001-07-05 | 2003-01-23 | R.T. Alamo Ventures I, Inc. | Sublingual administration of dihydroergotamine for the treatment of migraine |
EP1421458B1 (en) | 2001-08-03 | 2010-04-07 | Hill-Rom Services, Inc. | Patient point-of-care computer system |
US7044302B2 (en) | 2001-09-19 | 2006-05-16 | Avancen, Inc. | Patient controlled timed oral medication dispenser |
US7743923B2 (en) | 2001-09-19 | 2010-06-29 | Avanced MOD Corporation | Patient controlled timed medication dispenser |
JP2005506885A (en) | 2001-10-22 | 2005-03-10 | スリーエム イノベイティブ プロパティズ カンパニー | Transdermal / transmucosal patch packaging |
CA2366887C (en) | 2001-12-31 | 2011-11-01 | Michael Petersen | Replicate incorporating an electronic content monitoring system for use in form-fill-seal applications |
ES2563981T3 (en) | 2002-02-22 | 2016-03-17 | Gw Pharma Limited | Dose delivery system and apparatus |
US7074426B2 (en) | 2002-03-27 | 2006-07-11 | Frank Kochinke | Methods and drug delivery systems for the treatment of orofacial diseases |
US6786883B2 (en) * | 2002-04-15 | 2004-09-07 | Ronald D. Shippert | Applicator for insertion of cargo into a body cavity |
GB0209783D0 (en) | 2002-04-29 | 2002-06-05 | Glaxo Group Ltd | Medicament dispenser |
US6961541B2 (en) | 2002-05-24 | 2005-11-01 | Aeroscout, Inc. | Method and apparatus for enhancing security in a wireless network using distance measurement techniques |
US6793075B1 (en) | 2002-05-30 | 2004-09-21 | Michael Jeter | Container for dispensing a liquid and method of using the same |
NO314833B1 (en) | 2002-05-31 | 2003-06-02 | Reza Hezari | Stikkpilleapplikator |
DK2058754T3 (en) | 2002-06-21 | 2013-07-22 | Glaxo Group Ltd | Activity indicator for a dispensing device |
PT1539366E (en) | 2002-08-06 | 2009-06-19 | Glaxo Group Ltd | A dispenser |
US7619819B2 (en) | 2002-08-20 | 2009-11-17 | Illumina, Inc. | Method and apparatus for drug product tracking using encoded optical identification elements |
US9486581B2 (en) | 2002-09-11 | 2016-11-08 | Becton, Dickinson And Company | Injector device with force lock-out and injection rate limiting mechanisms |
US20050203542A1 (en) | 2002-09-18 | 2005-09-15 | Allergan, Inc. | Apparatus for delivery of ocular implants with reduced incidence of ocular adverse events |
US7295890B2 (en) | 2002-09-26 | 2007-11-13 | Stratamed Labs, Inc. | Prescription drug compliance monitoring system |
US6963289B2 (en) | 2002-10-18 | 2005-11-08 | Aeroscout, Ltd. | Wireless local area network (WLAN) channel radio-frequency identification (RFID) tag system and method therefor |
US6726053B1 (en) | 2002-10-29 | 2004-04-27 | John E. Harrold | Child resistant multiple dosage blister pack dispenser |
GB0226022D0 (en) | 2002-11-07 | 2002-12-18 | Corporate Intellectual Propert | Device |
US6960183B2 (en) | 2002-12-02 | 2005-11-01 | Nicolette Jon R | Veterinary pill and capsule delivery device |
US7264139B2 (en) * | 2003-01-14 | 2007-09-04 | Hypoguard Limited | Sensor dispensing device |
KR20050096950A (en) | 2003-01-31 | 2005-10-06 | 오렉쏘 에이비 | A rapid-acting pharmaceutical composition |
US20040253307A1 (en) | 2003-02-04 | 2004-12-16 | Brian Hague | Sugar-free oral transmucosal solid dosage forms and uses thereof |
US20040158194A1 (en) | 2003-02-06 | 2004-08-12 | Wolff Andy And Beiski Ben Z. | Oral devices and methods for controlled drug release |
GB0305581D0 (en) | 2003-03-11 | 2003-04-16 | Dallas Burston Ltd | Dispensing devices |
US7042357B2 (en) * | 2003-03-26 | 2006-05-09 | Proximities, Inc. | Non-reusable identification device |
US6914668B2 (en) | 2003-05-14 | 2005-07-05 | International Technologies (Laser) Ltd. | Personal identification verification and controlled substance detection and identification system |
US7819847B2 (en) | 2003-06-10 | 2010-10-26 | Hewlett-Packard Development Company, L.P. | System and methods for administering bioactive compositions |
US7118550B2 (en) * | 2003-07-10 | 2006-10-10 | B. Braun Medical | Side-delivery suppository dispenser |
US20070005005A1 (en) | 2003-08-29 | 2007-01-04 | Wang Fang N | Method and apparatus for dosing solids |
US20050049464A1 (en) | 2003-08-29 | 2005-03-03 | Lassers Harold Aaron | Remote pharmaceutical administration device |
US7248165B2 (en) | 2003-09-09 | 2007-07-24 | Motorola, Inc. | Method and apparatus for multiple frequency RFID tag architecture |
GB0322284D0 (en) | 2003-09-23 | 2003-10-22 | Glaxo Group Ltd | Medicament dispenser |
US8157788B2 (en) | 2003-11-06 | 2012-04-17 | Paolo L. Manfredi | Multi-site drug delivery platform |
US7540998B2 (en) | 2003-11-19 | 2009-06-02 | Biocompatibles Uk Limited | Delivery system and prescription method for interstitial radiation therapy using enhanced parametric release sterilization techniques |
US7780973B2 (en) | 2003-12-15 | 2010-08-24 | Ethicon Endo-Surgery, Inc. | Method and device for minimally invasive implantation of biomaterial |
US6999028B2 (en) | 2003-12-23 | 2006-02-14 | 3M Innovative Properties Company | Ultra high frequency radio frequency identification tag |
US20050150489A1 (en) | 2004-01-12 | 2005-07-14 | Steve Dunfield | Dispensing medicaments based on rates of medicament action |
EP1711220A1 (en) | 2004-01-16 | 2006-10-18 | Biodel, Inc. | Sublingual drug delivery device |
US7004111B2 (en) | 2004-05-26 | 2006-02-28 | Keryl Olson | Treat dispenser |
US8073548B2 (en) * | 2004-08-24 | 2011-12-06 | Sensors For Medicine And Science, Inc. | Wristband or other type of band having an adjustable antenna for use with a sensor reader |
US7388493B2 (en) | 2004-10-08 | 2008-06-17 | Bartronics America, Inc. | Method and system for preventing unauthorized removal and use of an RFID apparatus |
US7119690B2 (en) | 2004-10-08 | 2006-10-10 | Proximities, Inc. | Identification band using serpentine paths to detect tampering |
US8142733B2 (en) * | 2004-10-21 | 2012-03-27 | Bayer Healthcare Llc | Sensor-dispensing device and mechanism for extracting sensor |
US20060089858A1 (en) | 2004-10-25 | 2006-04-27 | Tun Ling | Means and method of applying RFID and PKI technologies for patient safety |
US7587259B2 (en) | 2005-05-03 | 2009-09-08 | University Of Rochester | Items dispenser |
US20070074722A1 (en) | 2005-09-21 | 2007-04-05 | Kurve Technology, Inc. | Medicament delivery control, monitoring, and reporting system and method |
JP5586151B2 (en) | 2005-12-13 | 2014-09-10 | バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド | Abuse-resistant transmucosal drug delivery device |
US9289583B2 (en) | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US8202535B2 (en) | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
US7581657B2 (en) * | 2006-05-15 | 2009-09-01 | Dickmann Alexander J | Bandage dispenser |
US20070286900A1 (en) | 2006-06-09 | 2007-12-13 | Catherine Herry | Low dose tablets of opioid analgesics and preparation process |
JP3133186U (en) * | 2007-04-17 | 2007-07-05 | 岡崎産業株式会社 | Bra wash case |
US7744558B2 (en) * | 2007-06-06 | 2010-06-29 | Maag R John | Pill plunger |
US20090010992A1 (en) | 2007-07-03 | 2009-01-08 | Aceirx Pharmaceuticals, Inc. | Drug formulations for oral transmucosal delivery to pediatric patients |
EP3269346A1 (en) | 2007-08-07 | 2018-01-17 | Acelrx Pharmaceuticals, Inc. | Apparatus for oral drug delivery |
EP2197415B1 (en) | 2007-09-20 | 2014-03-05 | Lapidot Medical Import And Marketing Ltd | Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endrometriosis, adenomyosis and related disorders by mifepristone |
US20100090966A1 (en) * | 2008-10-14 | 2010-04-15 | Immersion Corporation | Capacitive Sensor Gloves |
US8972048B2 (en) * | 2008-11-20 | 2015-03-03 | Disney Enterprises, Inc. | Self-service beverage and snack dispensing using identity-based access control |
US8945592B2 (en) | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
GB2467904B (en) | 2009-02-17 | 2013-06-12 | Oval Medical Technologies Ltd | Drug container and delivery mechanism |
WO2010107761A1 (en) | 2009-03-18 | 2010-09-23 | Acelrx Pharmaceuticals, Inc. | Improved storage and dispensing devices for administration of oral transmucosal dosage forms |
US8062248B2 (en) * | 2009-07-14 | 2011-11-22 | Charles Edward Kindel | Pill dispenser for pets |
TW201127435A (en) | 2009-09-30 | 2011-08-16 | Sanofi Aventis Deutschland | Drive mechanism for a drug delivery device |
US20110091544A1 (en) | 2009-10-16 | 2011-04-21 | Acelrx Pharmaceuticals, Inc. | Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
US8241299B2 (en) | 2009-10-22 | 2012-08-14 | Devicor Medical Products, Inc. | Biopsy marker delivery configured to retain marker prior to intended deployment |
US20110288128A1 (en) | 2010-05-21 | 2011-11-24 | Acelrx Pharmaceuticals, Inc. | Oral Transmucosal Administration of Sufentanil |
JP5712814B2 (en) * | 2010-11-12 | 2015-05-07 | セイコーエプソン株式会社 | Electronic clock with built-in antenna |
TWI417120B (en) | 2011-05-27 | 2013-12-01 | Leader Machine Co Ltd | A drug delivery device with built - in quantitative pusher |
DE102012104058A1 (en) | 2012-05-09 | 2013-11-14 | Sfm Medical Devices Gmbh | Cannula with displaceable stylet |
EP2903670B1 (en) | 2012-10-05 | 2017-04-19 | Carebay Europe Ltd. | Medicament delivery device |
MX2015012901A (en) | 2013-03-14 | 2016-04-04 | Norton Healthcare Ltd | Dispensing mechanism for a medical device. |
CN203898925U (en) | 2014-06-16 | 2014-10-29 | 张雪英 | Drug applying device for dermatological department |
AU2015369710B2 (en) | 2014-12-23 | 2020-09-17 | Vertical Pharmaceuticals, Llc | Systems, devices and methods for dispensing oral transmucosal dosage forms |
-
2010
- 2010-03-16 WO PCT/US2010/027437 patent/WO2010107761A1/en active Application Filing
- 2010-03-16 US US12/724,634 patent/US8548623B2/en active Active
-
2012
- 2012-03-09 US US13/416,236 patent/US8574189B2/en active Active
-
2013
- 2013-09-30 US US14/041,963 patent/US20140031975A1/en not_active Abandoned
-
2016
- 2016-10-13 US US15/292,909 patent/US20170098057A1/en not_active Abandoned
-
2018
- 2018-09-26 US US16/143,046 patent/US10896751B2/en active Active
-
2021
- 2021-01-15 US US17/150,450 patent/US11676691B2/en active Active
-
2023
- 2023-05-01 US US18/141,689 patent/US20230260612A1/en active Pending
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080203107A1 (en) * | 2001-09-19 | 2008-08-28 | Conley N Sharon | Patient controlled timed medication dispenser |
US20030173408A1 (en) * | 2002-03-18 | 2003-09-18 | Precision Dynamics Corporation | Enhanced identification appliance |
WO2007081947A2 (en) | 2006-01-06 | 2007-07-19 | Acelrx Pharmaceuticals, Inc. | Drug storage and dispensing devices and systems comprising the same |
US20070186923A1 (en) | 2006-01-06 | 2007-08-16 | Aceirx Pharmaceuticals, Inc. | Drug storage and dispensing devices and systems comprising the same |
US20070207207A1 (en) | 2006-01-06 | 2007-09-06 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US20080268023A1 (en) | 2006-01-06 | 2008-10-30 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US20070260491A1 (en) | 2006-05-08 | 2007-11-08 | Pamela Palmer | System for delivery and monitoring of administration of controlled substances |
US20070299687A1 (en) | 2006-06-23 | 2007-12-27 | Pamela Palmer | Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed |
US20080166404A1 (en) | 2007-01-05 | 2008-07-10 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
WO2008085764A1 (en) | 2007-01-05 | 2008-07-17 | Acelrx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
WO2008085765A2 (en) | 2007-01-05 | 2008-07-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
WO2008085763A1 (en) | 2007-01-05 | 2008-07-17 | Acelrx Pharmaceuticals, Inc. | Storage and dispensing devices for adminsistration of oral transmucosal dosage forms |
US20080164275A1 (en) | 2007-01-05 | 2008-07-10 | Acelrx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
Non-Patent Citations (1)
Title |
---|
HICKS ET AL., JOINT COMMISSION ON QUALITY AND PATIENT SAFETY, vol. 34, no. 12, 2008, pages 734 - 742 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014199374A1 (en) * | 2013-06-09 | 2014-12-18 | Vaica Medical Ltd. | Automated medication dispensing and related applications thereof |
CN103315815A (en) * | 2013-06-25 | 2013-09-25 | 四川品杰科技有限公司 | RFID (radiofrequency identification) wrist strap |
Also Published As
Publication number | Publication date |
---|---|
US20120232473A1 (en) | 2012-09-13 |
US11676691B2 (en) | 2023-06-13 |
US20140031975A1 (en) | 2014-01-30 |
US8574189B2 (en) | 2013-11-05 |
US20100253476A1 (en) | 2010-10-07 |
US8548623B2 (en) | 2013-10-01 |
US10896751B2 (en) | 2021-01-19 |
US20210151153A1 (en) | 2021-05-20 |
US20170098057A1 (en) | 2017-04-06 |
US20230260612A1 (en) | 2023-08-17 |
US20190027241A1 (en) | 2019-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11676691B2 (en) | Storage and dispensing devices for administration of oral transmucosal dosage forms | |
JP5322949B2 (en) | Storage and administration device for administration of oral mucosal dosage forms | |
US10709881B2 (en) | Apparatus for administering small volume oral transmucosal dosage forms | |
US8778393B2 (en) | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | |
US8357114B2 (en) | Drug dispensing device with flexible push rod | |
JP6138196B2 (en) | Storage and administration device for administration of transmucosal dosage forms | |
JP2010532745A (en) | Sufentanil containing small volume oral cavity mucosa dosage form for the treatment of pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10711107 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10711107 Country of ref document: EP Kind code of ref document: A1 |